Bionano Genomics, Inc. ( BNGO) - Key Metrics
BNGO Revenue per Share metrics
| Date | Revenue per Share | Net Income per Share | Operating Cash Flow | Free Cash Flow per Share |
|---|---|---|---|---|
| 2026Q2 | $0.71 | -$0.64 | -$0.40 | -$0.40 |
| 2026Q1 | $0.61 | -$0.76 | -$0.52 | -$0.52 |
| 2025Q4 | $0.74 | -$0.74 | -$0.39 | -$0.39 |
| 2025Q3 | $1.38 | -$1.59 | -$1.11 | -$1.11 |
| 2025Q2 | $1.96 | -$1.99 | -$1.01 | -$1.01 |
BNGO Payout ratio and Price per Earnings ratio
| Date | Payout ratio | PE ratio |
|---|---|---|
| 2026Q2 | 0% | -0.44 |
| 2026Q1 | 0% | -0.38 |
| 2025Q4 | 0% | -0.52 |
| 2025Q3 | 0% | -0.27 |
| 2025Q2 | 0% | -0.41 |
BNGO
Price: $1.31
52 week price:
Earnings Per Share: -3.01 USD
Exchange: NCM
Sector: Healthcare
Industry: Medical Instruments & Supplies
Country: United States
Volume: 6.9 million
Market Capitalization: 16.8 million